High post-treatment serum levels of soluble programmed cell death ligand 1 predict early relapse and poor prognosis in extranodal NK/T cell lymphoma patients

The impact of serum levels of soluble programmed cell death ligand 1 (sPD-L1) on prognosis in patients with Epstein-Barr virus-associated malignancies has never been investigated. We prospectively measured pre- and post-treatment serum sPD-L1 levels and evaluated their prognostic value in 97 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hua, Wang, Liang, Liu, Wen-Jian, Xia, Zhong-Jun, Huang, Hui-Qiang, Jiang, Wen-Qi, Li, Zhi-Ming, Lu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078073/
https://www.ncbi.nlm.nih.gov/pubmed/27105512
http://dx.doi.org/10.18632/oncotarget.8847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078073/
https://www.ncbi.nlm.nih.gov/pubmed/27105512
http://dx.doi.org/10.18632/oncotarget.8847

Ejemplares similares